These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 31628139)
1. Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows. Lampignano R; Neumann MHD; Weber S; Kloten V; Herdean A; Voss T; Groelz D; Babayan A; Tibbesma M; Schlumpberger M; Chemi F; Rothwell DG; Wikman H; Galizzi JP; Riise Bergheim I; Russnes H; Mussolin B; Bonin S; Voigt C; Musa H; Pinzani P; Lianidou E; Brady G; Speicher MR; Pantel K; Betsou F; Schuuring E; Kubista M; Ammerlaan W; Sprenger-Haussels M; Schlange T; Heitzer E Clin Chem; 2020 Jan; 66(1):149-160. PubMed ID: 31628139 [TBL] [Abstract][Full Text] [Related]
2. Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing. Hellwig S; Nix DA; Gligorich KM; O'Shea JM; Thomas A; Fuertes CL; Bhetariya PJ; Marth GT; Bronner MP; Underhill HR PLoS One; 2018; 13(7):e0197333. PubMed ID: 30044795 [TBL] [Abstract][Full Text] [Related]
3. Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling. van der Leest P; Ketelaar EM; van Noesel CJM; van den Broek D; van Boerdonk RAA; Deiman B; Rifaela N; van der Geize R; Huijsmans CJJ; Speel EJM; Geerlings MJ; van Schaik RHN; Jansen MPHM; Dane-Vogelaar R; Driehuis E; Leers MPG; Sidorenkov G; Tamminga M; van Kempen LC; Schuuring E Clin Chem; 2022 Jul; 68(7):963-972. PubMed ID: 35616097 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients. Leest PV; Boonstra PA; Elst AT; Kempen LCV; Tibbesma M; Koopmans J; Miedema A; Tamminga M; Groen HJM; Reyners AKL; Schuuring E Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414097 [TBL] [Abstract][Full Text] [Related]
5. Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular Analysis. Till JE; Black TA; Gentile C; Abdalla A; Wang Z; Sangha HK; Roth JJ; Sussman R; Yee SS; O'Hara MH; Thompson JC; Aggarwal C; Hwang WT; Elenitoba-Johnson KSJ; Carpenter EL J Mol Diagn; 2021 Nov; 23(11):1545-1552. PubMed ID: 34454115 [TBL] [Abstract][Full Text] [Related]
6. A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCR. Cavallone L; Aldamry M; Lafleur J; Lan C; Gonzalez Ginestet P; Alirezaie N; Ferrario C; Aguilar-Mahecha A; Basik M Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):909-916. PubMed ID: 30824523 [TBL] [Abstract][Full Text] [Related]
7. Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma. Affolter KE; Hellwig S; Nix DA; Bronner MP; Thomas A; Fuertes CL; Hamil CL; Garrido-Laguna I; Scaife CL; Mulvihill SJ; Underhill HR Neoplasia; 2021 Sep; 23(9):859-869. PubMed ID: 34298235 [TBL] [Abstract][Full Text] [Related]
8. Comparison of methods for isolation and quantification of circulating cell-free DNA from patients with endometriosis. Huebner H; Lubrich H; Blum S; Antoniadis S; Lermann J; Ekici A; Fasching PA; Beckmann MW; Ruebner M; Burghaus S Reprod Biomed Online; 2021 Nov; 43(5):788-798. PubMed ID: 34493460 [TBL] [Abstract][Full Text] [Related]
9. External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium. van der Leest P; Rozendal P; Hinrichs J; van Noesel CJM; Zwaenepoel K; Deiman B; Huijsmans CJJ; van Eijk R; Speel EJM; van Haastert RJ; Ligtenberg MJL; van Schaik RHN; Jansen MPHM; Dubbink HJ; de Leng WW; Leers MPG; Tamminga M; van den Broek D; van Kempen LC; Schuuring E Clin Chem; 2024 May; 70(5):759-767. PubMed ID: 38484302 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows. Lehle S; Emons J; Hack CC; Heindl F; Hein A; Preuß C; Seitz K; Zahn AL; Beckmann MW; Fasching PA; Ruebner M; Huebner H Sci Rep; 2023 Jan; 13(1):373. PubMed ID: 36611077 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Evaluation of the Factors Affecting Plasma Circulating Cell-Free DNA Levels and Their Application in Diagnosing Nonsmall Cell Lung Cancer. Chen Z; Zhang S; Li C; Xu C; Zhao J; Miao L Genet Test Mol Biomarkers; 2019 Apr; 23(4):270-276. PubMed ID: 30986099 [TBL] [Abstract][Full Text] [Related]
12. Analysis of colorectal cancer-related mutations by liquid biopsy: Utility of circulating cell-free DNA and circulating tumor cells. Takeda K; Yamada T; Takahashi G; Iwai T; Ueda K; Kuriyama S; Koizumi M; Matsuda A; Shinji S; Ohta R; Yokoyama Y; Hotta M; Hara K; Yoshida H Cancer Sci; 2019 Nov; 110(11):3497-3509. PubMed ID: 31465598 [TBL] [Abstract][Full Text] [Related]
13. Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular Profiling. van der Leest P; Schuuring E Clin Chem; 2024 Jan; 70(1):220-233. PubMed ID: 38175597 [TBL] [Abstract][Full Text] [Related]
14. Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows. Kloten V; Neumann MHD; Di Pasquale F; Sprenger-Haussels M; Shaffer JM; Schlumpberger M; Herdean A; Betsou F; Ammerlaan W; Af Hällström T; Serkkola E; Forsman T; Lianidou E; Sjöback R; Kubista M; Bender S; Lampignano R; Krahn T; Schlange T; Clin Chem; 2019 Sep; 65(9):1132-1140. PubMed ID: 31235535 [TBL] [Abstract][Full Text] [Related]
15. Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision Oncology? Underhill HR Mol Diagn Ther; 2021 Jul; 25(4):389-408. PubMed ID: 34018157 [TBL] [Abstract][Full Text] [Related]
16. Interlaboratory evaluation of quality control methods for circulating cell-free DNA extraction. Devonshire A; Jones G; Gonzalez AF; Kofanova O; Trouet J; Pinzani P; Gelmini S; Bonin S; Foy C N Biotechnol; 2023 Dec; 78():13-21. PubMed ID: 37730172 [TBL] [Abstract][Full Text] [Related]
17. Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer. Vietsch EE; Graham GT; McCutcheon JN; Javaid A; Giaccone G; Marshall JL; Wellstein A Cancer Genet; 2017 Dec; 218-219():39-50. PubMed ID: 29153095 [TBL] [Abstract][Full Text] [Related]
18. Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience. Malentacchi F; Pizzamiglio S; Verderio P; Pazzagli M; Orlando C; Ciniselli CM; Günther K; Gelmini S Clin Chem Lab Med; 2015 Nov; 53(12):1935-42. PubMed ID: 25883202 [TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients. Schmidt B; Reinicke D; Reindl I; Bork I; Wollschläger B; Lambrecht N; Fleischhacker M Clin Chim Acta; 2017 Jun; 469():94-98. PubMed ID: 28373054 [TBL] [Abstract][Full Text] [Related]
20. Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence. Pasternack H; Fassunke J; Plum PS; Chon SH; Hescheler DA; Gassa A; Merkelbach-Bruse S; Bruns CJ; Perner S; Hallek M; Büttner R; Bollschweiler E; Hölscher AH; Quaas A; Zander T; Weiss J; Alakus H Sci Rep; 2018 Oct; 8(1):14941. PubMed ID: 30297788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]